Prognostic Value of New-Generation Troponins in ST-Segment-Elevation Myocardial Infarction in the Modern Era: The RUTI-STEMI Study
Related Experiment Video
Updated: Feb 16, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Germán Cediel1,2, Ferran Rueda1,2, Cosme García1,2
1Heart Institute, Hospital Universitari Germans Trias i Pujol, Badalona (Barcelona), Spain.
Insights
New-generation troponins do not significantly predict clinical events in ST-segment-elevation myocardial infarction (STEMI) patients. These cardiac biomarkers offer limited prognostic value for risk stratification in STEMI management.
Area of Science:
- Cardiology
- Biomarkers
- Clinical Research
Background:
- Diagnosis of ST-segment-elevation myocardial infarction (STEMI) relies on symptoms and ECG, not troponins.
- New-generation troponins are increasingly used, but their prognostic value in STEMI requires further investigation.
Purpose of the Study:
- To evaluate the prognostic significance of new-generation troponins (high-sensitivity troponin T and sensitive-contemporary troponin I) in a real-world STEMI cohort.
- To determine if peak troponin levels predict major adverse cardiovascular and cerebrovascular events (MACCEs) in STEMI patients treated with percutaneous coronary intervention.
Main Methods:
- A cohort of 1260 STEMI patients treated with percutaneous coronary intervention was analyzed.
- Clinical data, peak high-sensitivity troponin T, and sensitive-contemporary troponin I levels were collected.
- Multivariable Cox regression was used to assess predictors of MACCEs at 30 days and 1 year.
Main Results:
- Age, Killip-Kimball class, and left ventricular ejection fraction were independent predictors of short-term MACCEs.
- Neither peak high-sensitivity troponin T nor sensitive-contemporary troponin I levels were significant predictors of short-term or long-term MACCEs.
- Long-term MACCEs were associated with age, female sex, diabetes, prior coronary artery disease, Killip-Kimball class, and LVEF.
Conclusions:
- New-generation troponins do not provide significant prognostic information for predicting clinical events in STEMI.
- The utility of serial troponin measurements for risk stratification in STEMI should be reconsidered.
Background:
In ST-segment-elevation myocardial infarction (STEMI), troponins are not needed for diagnosis: symptoms and ECG data are sufficient to activate percutaneous coronary intervention. This study explored the prognostic value of new-generation troponins in a real-life cohort contemporarily treated for STEMI.
Methods And Results:
We studied 1260 consecutive patients with primary STEMI treated with percutaneous coronary intervention between February 22, 2011, and August 31, 2015. We collected data on clinical characteristics and major adverse cardiovascular and cerebrovascular events (MACCEs) at 30 days and 1 year. Peak high-sensitivity troponin T and sensitive-contemporary troponin I levels were recorded. MACCEs occurred in 75 patients (6.1%) by day 30 and in 124 patients (10.8%) between day 31 and 1 year. A short-term (0-30 days) multivariable Cox regression analysis revealed that age, Killip-Kimball class, and left ventricular ejection fraction were independent predictors of MACCEs. In adjusted analysis, peak high-sensitivity troponin T and sensitive-contemporary troponin I were not significant (hazard ratio, 1.23 [95% confidence interval, 0.98-1.54] [P=0.071]; and hazard ratio, 1.15 [95% confidence interval, 0.93-1.43] [P=0.200], respectively). A long-term (31 days-1 year) multivariable Cox regression analysis revealed that age, female sex, diabetes mellitus, prior coronary artery disease, Killip-Kimball class, and left ventricular ejection fraction were statistically significantly associated with MACCEs. However, peak high-sensitivity troponin T and peak sensitive-contemporary troponin I were not significantly associated with MACCEs (hazard ratio, 1.03 [95% confidence interval, 0.88-1.20] [P=0.715]; and hazard ratio, 0.99 [95% confidence interval, 0.85-1.15] [P=0.856], respectively).
Conclusions:
In the modern era, new-generation troponins do not provide significant prognostic information for predicting clinical events in STEMI. We should reconsider the value of serial troponin measurements for risk stratification in STEMI.
Related Concept Videos
Freezing Point Depression and Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
Modern Molecular Taxonomy
Elevation of Intermediate Points on Vertical Curves
Case Studies
DC Generator
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....

